<?xml version="1.0" encoding="UTF-8"?><rss version="0.92">
<channel>
	<title>Asbestos Lawyers</title>
	<link>http://www.asbestos-lawyers.net</link>
	<description></description>
	<lastBuildDate>Fri, 09 Mar 2012 00:25:15 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	<!-- generator="WordPress/3.2.1" -->

	<item>
		<title>Pradaxa Lawsuit News</title>
		<description><![CDATA[Pradaxa Lawsuit News - 2/29/2012: Did you take Pradaxa? Please contact us today if you took Pradaxa and later experienced harmful side effects. We will connect you with a lawyer that is experienced in complex litigation that may be able to help you recover monetary damages. Pradaxa Lawsuit: Intracerebral hemorrhage (ICH) accounts for 10-15% of [...]]]></description>
		<link>http://www.asbestos-lawyers.net/pradaxa-lawsuit-news-10/</link>
			</item>
	<item>
		<title>Pradaxa Lawsuit News</title>
		<description><![CDATA[Pradaxa Lawsuit : By far the most important modifiable risk factor for spontaneous ICH is HTN.Primary hypertensive hemorrhage results from the rupture of small penetrating arteries originating in the anterior, middle (i.e., lenticulostriate), and posterior cerebral (i.e., thalamostriate) arteries and the pons (i.e., paramedian perforators). HTN causes vessel rupture at or near the bifurcation of [...]]]></description>
		<link>http://www.asbestos-lawyers.net/pradaxa-lawsuit-news-9/</link>
			</item>
	<item>
		<title>Pradaxa Lawsuit News</title>
		<description><![CDATA[Pradaxa Lawsuit : Venous occlusive intracranial disease is associated with oral contraceptive use the immediate post-partum period, and a wide range of hypercoagulable medical conditions. Significant cerebral venous thrombosis involves one or more of the major venous sinuses and typically results in parenchymal hemorrhage. By definition, the territories of the ischemic and hemorrhagic lesions are [...]]]></description>
		<link>http://www.asbestos-lawyers.net/pradaxa-lawsuit-news-8/</link>
			</item>
	<item>
		<title>Pradaxa Lawsuit News</title>
		<description><![CDATA[Pradaxa Lawsuit: Commonly considered agents: beta-blockers (labetalol, esmo­lol), calcium channel blockers (nicardipine), angiotensin con­verting enzyme (ACE) inhibitors (enalapril), and hydralazine. Other agents such as nitroprusside are effective as second-line options but carry the risk of significant vasodilation.Mass effect causing significant elevation of ICP, with the risk for cerebral herniation syndromes, may be managed emergently with [...]]]></description>
		<link>http://www.asbestos-lawyers.net/pradaxa-lawsuit-news-7/</link>
			</item>
	<item>
		<title>Pradaxa Lawsuit News</title>
		<description><![CDATA[Pradaxa Lawsuit : By far the most important modifiable risk factor for spontaneous ICH is HTN.Primary hypertensive hemorrhage results from the rupture of small penetrating arteries originating in the anterior, middle (i.e., lenticulostriate), and posterior cerebral (i.e., thalamostriate) arteries and the pons (i.e., paramedian perforators). HTN causes vessel rupture at or near the bifurcation of [...]]]></description>
		<link>http://www.asbestos-lawyers.net/pradaxa-lawsuit-news-6/</link>
			</item>
	<item>
		<title>Pradaxa Lawsuit News</title>
		<description><![CDATA[Pradaxa Lawsuit News &#8211; 3/1/2012: Did you take Pradaxa? Please contact us today if you took Pradaxa and later experienced harmful side effects. We will connect you with a lawyer that is experienced in complex litigation that may be able to help you recover monetary damages. Pradaxa Lawsuit: Intracerebral hemorrhage (ICH) accounts for 10-15% of [...]]]></description>
		<link>http://www.asbestos-lawyers.net/pradaxa-lawsuit-news-5/</link>
			</item>
	<item>
		<title>Pradaxa Lawsuit News</title>
		<description><![CDATA[Pradaxa Lawsuit: More information about your search Pradaxa Lawsuit: By far the most important modifiable risk factor for spontaneous ICH is HTN. Primary hypertensive hemorrhage results from the rupture of small penetrating arteries originating in the anterior, middle (i.e., lenticulostriate), and posterior cerebral (i.e., thalamostriate) arteries and the pons (i.e., paramedian perforators). HTN causes vessel [...]]]></description>
		<link>http://www.asbestos-lawyers.net/pradaxa-lawsuit-news-4/</link>
			</item>
	<item>
		<title>Pradaxa Lawsuit News</title>
		<description><![CDATA[Pradaxa Lawsuit Pradaxa Lawsuit: Venous occlusive intracranial disease is associated with oral contraceptive use the immediate post-partum period, and a wide range of hypercoagulable medical conditions. Significant cerebral venous thrombosis involves one or more of the major venous sinuses and typically results in parenchymal hemorrhage. By definition, the territories of the ischemic and hemorrhagic lesions [...]]]></description>
		<link>http://www.asbestos-lawyers.net/pradaxa-lawsuit-news-3/</link>
			</item>
	<item>
		<title>Pradaxa Lawsuit News</title>
		<description><![CDATA[Pradaxa Lawsuit: News and Information from related Sources Pradaxa Lawsuit: Various clinical trials, including SHEP (Systolic Hypertension in the Elderly Program)and PROGRESS (Perindopril Protection Against Recurrent Stroke Study), have documented the critical role of antihypertensive agents in both primary and secondary stroke prevention of ICH. The JNC-7 report (Seventh Report of the Joint National Committee [...]]]></description>
		<link>http://www.asbestos-lawyers.net/pradaxa-lawsuit-news-2/</link>
			</item>
	<item>
		<title>Pradaxa Lawsuit News</title>
		<description><![CDATA[Pradaxa Lawsuit: News and Information from related Sources Pradaxa Lawsuit: A 36-year-old patient with a known history of HTN and reportedly excessive use of a weight-loss agent and stimulant, xenedrine, presented with an evolving large, left subcortical ICH. Despite aggressive neurocritical care, with ICP monitoring, cerebrospinal fluid (CSF) drainage and hypertonic saline, the patient died [...]]]></description>
		<link>http://www.asbestos-lawyers.net/pradaxa-lawsuit-news/</link>
			</item>
</channel>
</rss>

